CARDIUM THERAPEUTICS AND ARIES VENTURES ANNOUNCE MERGER

Privately held Cardium Therapeutics, Inc. today announced its merger with a specially formed subsidiary of Aries Ventures Inc. Cardium Therapeutics and Aries Ventures (the Company) will be headquartered in San Diego and will continue to trade under the Aries Ventures name and ticker symbol until the completion of its corporate name change to Cardium Therapeutics, Inc. In addition to the merger and equity financing, the Company also announced the strategic acquisition of a portfolio of cardiovascular product candidates from Schering AG Germany.

American Venture Magazine (http://www.americanventuremagazine.com/news.php?newsid=436)